{"DataElement":{"publicId":"14742322","version":"1","preferredName":"Tumor Response Supplemental Qualifiers Dataset Neoplasm Involvement Percentage Most Involved Side Percentage Value","preferredDefinition":"Numeric value that represents the tumor involvement percentage of the most involved side.","longName":"SUPPTR_QVAL_PCTTUMINVLSIDE","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14742317","version":"1","preferredName":"Tumor Response Supplemental Qualifiers Dataset Neoplasm Involvement Percentage Most Involved Side","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the tumor response domain.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._To have a connection by participation or association or use; sharing in an activity or process._A fraction or ratio with 100 understood as the denominator._Greatest in amount, extent, or degree; constituting a majority._To have a connection by participation or association or use; sharing in an activity or process._One of the two lateral margins or surfaces of a body, midway between the front and back.","longName":"14375938v1.00:14742316v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"14375938","version":"1","preferredName":"Tumor Response Supplemental Qualifiers Dataset","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the tumor response domain.","longName":"C147261","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Response Supplemental Qualifiers Dataset","conceptCode":"C147261","definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the tumor response domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"02E6B2F1-0674-38CC-E063-731AD00A0BAC","latestVersionIndicator":"Yes","beginDate":"2023-08-14","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-08-14","modifiedBy":"MMADDINENI","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14742316","version":"1","preferredName":"Neoplasm Involvement Percentage Most Involvement Side","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._To have a connection by participation or association or use; sharing in an activity or process._A fraction or ratio with 100 understood as the denominator._Greatest in amount, extent, or degree; constituting a majority._To have a connection by participation or association or use; sharing in an activity or process._One of the two lateral margins or surfaces of a body, midway between the front and back.","longName":"14742316v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Most","conceptCode":"C25258","definition":"Greatest in amount, extent, or degree; constituting a majority.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Side","conceptCode":"C25306","definition":"One of the two lateral margins or surfaces of a body, midway between the front and back.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10CDA7D3-2CF9-4C5C-E063-731AD00A0BC6","latestVersionIndicator":"Yes","beginDate":"2024-02-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-07","modifiedBy":"MMADDINENI","dateModified":"2024-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10CDA7D3-2CFA-4C5C-E063-731AD00A0BC6","latestVersionIndicator":"Yes","beginDate":"2024-02-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-07","modifiedBy":"MMADDINENI","dateModified":"2024-02-07","changeDescription":null,"administrativeNotes":"2/7/2024: Created DEC(CADSR0003335)- MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5976625","version":"1","preferredName":"Percentage Value","preferredDefinition":"A fraction or ratio with 100 understood as the denominator. A numerical quantity measured or assigned or computed.","longName":"5976625v1.0","context":"Theradex","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"58EB0D41-9729-3785-E053-F662850AD7CB","latestVersionIndicator":"Yes","beginDate":"2017-09-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-09-11","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released/PClark. 9/11/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the percentage tumor involvement from the most involved side?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"10CDF535-6909-601C-E063-731AD00A7306","latestVersionIndicator":"Yes","beginDate":"2024-02-07","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-07","modifiedBy":"MMADDINENI","dateModified":"2024-02-07","changeDescription":null,"administrativeNotes":"2/7/2024: Created CDE(CADSR0003335)- MM","unresolvedIssues":null,"deletedIndicator":"No"}}